Counselors in Fort Dodge, IA Accepting Medicare
81 Counselors found. Showing 1 - 20
 Cynthia Sue Wilson, LISW, CADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 728 1st Ave N, Fort Dodge, IA 50501 Phone: 515-571-1724 |
Tia Painter, CADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1506 31st Ave N, Fort Dodge, IA 50501 Phone: 515-576-7261 Fax: 515-955-7652 |
Rebecca Olson, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 111 Avenue O W, Fort Dodge, IA 50501 Phone: 515-573-2193 |
Alicia Deane Meldrem, CADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1506 31st Ave N, Fort Dodge, IA 50501 Phone: 515-576-7261 |
Katelyn Hofbauer Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 720 Kenyon Rd, Fort Dodge, IA 50501 Phone: 800-482-8305 |
Emily Schoon, TLMHC Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 720 Kenyon Rd, Fort Dodge, IA 50501 Phone: 800-482-8305 Fax: 515-573-7898 |
Melissa Donahe, CADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 726 S 17th St, Fort Dodge, IA 50501 Phone: 800-830-7009 |
Jeanette Lucille Moss, CADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 211 Avenue M W, Fort Dodge, IA 50501 Phone: 515-575-7261 |
Katie Talbot Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 211 Avenue M W, Fort Dodge, IA 50501 Phone: 515-576-7261 |
Carmen Clavin, CADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 726 S 17th St, Fort Dodge, IA 50501 Phone: 800-830-7009 |
Victoria Bell, CADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 726 S 17th St, Fort Dodge, IA 50501 Phone: 515-576-7261 |
 Michael John Ryan, BA, CADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 211 Avenue M W, Fort Dodge, IA 50501 Phone: 515-576-7261 |
Mrs. Andrea Marie Jondle-howard, IADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 211 Avenue M W, Fort Dodge, IA 50501 Phone: 515-576-7261 Fax: 515-955-7628 |
Ms. Linsey J Albright, T-LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 126 N 10th St, Fort Dodge, IA 50501 Phone: 515-576-6500 |
Blake V Harvey, CADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 726 S 17th St, Fort Dodge, IA 50501 Phone: 800-830-7009 |
Connie Harvey, CADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 726 S 17th St, Fort Dodge, IA 50501 Phone: 515-576-7261 Fax: 515-955-7628 |
Nicole L George Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 826 1st Ave N, Fort Dodge, IA 50501 Phone: 515-573-3931 Fax: 515-573-3950 |
Katherine Marie Hood, BSW, CADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 826 1st Ave N, Fort Dodge, IA 50501 Phone: 515-890-7048 Fax: 515-573-3950 |
Craig Sosby Counselor Medicare: Not Enrolled in Medicare Practice Location: 726 S 17th St, Fort Dodge, IA 50501 Phone: 800-830-7009 |
Dennis Michener, CADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 726 S 17th St, Fort Dodge, IA 50501 Phone: 866-801-0085 Fax: 515-955-7652 |
News Archive
Micromet initiates MT103 phase 2 trial in adult ALL patients
Micromet, Inc. today announced the initiation of a phase 2 trial of the Company's lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE antibodies, designed to harness the body's T cells to kill cancer cells.
Shire presents positive data from TKT-025 EXT Phase I/II study for VPRIV in type 1 Gaucher disease patients
Shire plc, the global specialty biopharmaceutical company, today announced positive data from its long-term extension to its open label Phase I/II study (TKT-025 EXT) for VPRIV® (velaglucerase alfa), the company's enzyme replacement therapy for patients with type 1 Gaucher disease. The data were presented at the 9th Annual European Working Group on Gaucher Disease (EWGGD) in Cologne, Germany, and add to the growing body of clinical evidence which supports the safety and sustained efficacy of VPRIV.
Medical journal articles published by women have fewer citations than those written by men
While more women are entering the field of academic medicine than ever before, they are less likely to be recognized as experts and leaders; they are less likely to receive prestigious awards, be promoted to full professorships, hold leadership roles, or author original research or commentaries in major journals.
Louse infestation calibrates immune system regulation
Some parasites can exert a moderating effect on the immune system, perhaps reducing the risk of developing immune dysfunctions like asthma, allergies and some forms of arthritis.
Even a little physical activity a day keeps Alzheimer's away
It is estimated that by 2030, the number of people with Alzheimer's disease worldwide is expected to double to 80 million. A new study shows a ray of hope. It found that daily physical activity might provide a person's best chances of staving off the degenerative brain disorder - even if they're over 80 years old.Additionally exercise does not have to be strenuous. Activities such as cooking and cleaning also led to a protective benefit.
› Verified 5 days ago
Counselors
Dentists
Pharmacists
Clinical Social Workers
Occupational Therapists
Marriage Counselors
Psychologists